Influenza Vaccine

Global (United States, European Union and China) Influenza Vaccine Market Research Report 2019-2025

Report ID: BMRC 5737 | Number of pages: 128 | Publish Date: Aug 2019 | Category: Lifesciences and Healthcare
Influenza vaccines are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza.
The European Centre for Disease Prevention and Control also recommends yearly vaccination of high risk groups. These groups include pregnant women, the elderly, children between six months and five years of age, those with other health problems, and those who work in healthcare.
In 2019, the market size of Influenza Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Influenza Vaccine. 

This report studies the global market size of Influenza Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia). 
This study presents the Influenza Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025. 
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
    AstraZeneca
    CSL
    GlaxoSmithKline
    Sanofi
    Altimmune
    BionVax
    FluGen
    Folia Biotech
    Genentech
    Green Cross
    Medicago
    Moderna Therapeutics
    Novavax
    Shijiazhuang Yiling Pharmaceutical
    SK Chemicals
    UNM Pharma
    Vaccitec

Market Segment by Product Type
    Fluzone/Vaxigrip
    FluMist
    Fluarix and Flulaval
    Anflu
    Fluvax/Afluria
    Flucelvax and Fluvirin

Market Segment by Application
    Adults
    Pediatrics
    Senior Citizens

Key Regions split in this report: breakdown data for each region.
    United States
    China
    European Union
    Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
    To analyze and research the Influenza Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
    To present the key Influenza Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
    To split the breakdown data by regions, type, companies and applications 
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends, drivers, influence factors in global and regions
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Influenza Vaccine are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
Interested in this report?
Get your sample now!
Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Major Manufacturers Covered in This Report
    1.3 Market Segment by Type
        1.3.1 Global Influenza Vaccine Market Size Growth Rate by Type (2019-2025)
        1.3.2 Fluzone/Vaxigrip
        1.3.3 FluMist
        1.3.4 Fluarix and Flulaval
        1.3.5 Anflu
        1.3.6 Fluvax/Afluria
        1.3.7 Flucelvax and Fluvirin
    1.4 Market Segment by Application
        1.4.1 Global Influenza Vaccine Market Share by Application (2019-2025)
        1.4.2 Adults
        1.4.3 Pediatrics
        1.4.4 Senior Citizens
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Influenza Vaccine Market Size
        2.1.1 Global Influenza Vaccine Revenue 2014-2025
        2.1.2 Global Influenza Vaccine Sales 2014-2025
    2.2 Influenza Vaccine Growth Rate by Regions
        2.2.1 Global Influenza Vaccine Sales by Regions 2014-2019
        2.2.2 Global Influenza Vaccine Revenue by Regions 2014-2019
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers

3 Market Share by Manufacturers
    3.1 Influenza Vaccine Sales by Manufacturers
        3.1.1 Influenza Vaccine Sales by Manufacturers 2014-2019
        3.1.2 Influenza Vaccine Sales Market Share by Manufacturers 2014-2019
    3.2 Revenue by Manufacturers
        3.2.1 Influenza Vaccine Revenue by Manufacturers (2014-2019)
        3.2.2 Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
        3.2.3 Global Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
    3.3 Influenza Vaccine Price by Manufacturers
    3.4 Key Manufacturers Influenza Vaccine Plants/Factories Distribution and Area Served
    3.5 Date of Key Manufacturers Enter into Influenza Vaccine Market
    3.6 Key Manufacturers Influenza Vaccine Product Offered
    3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Sales and Revenue for Each Type
        4.1.1 Fluzone/Vaxigrip Sales and Revenue (2014-2019)
        4.1.2 FluMist Sales and Revenue (2014-2019)
        4.1.3 Fluarix and Flulaval Sales and Revenue (2014-2019)
        4.1.4 Anflu Sales and Revenue (2014-2019)
        4.1.5 Fluvax/Afluria Sales and Revenue (2014-2019)
        4.1.6 Flucelvax and Fluvirin Sales and Revenue (2014-2019)
    4.2 Global Influenza Vaccine Sales Market Share by Type
    4.3 Global Influenza Vaccine Revenue Market Share by Type
    4.4 Influenza Vaccine Price by Type

5 Market Size by Application
    5.1 Overview
    5.2 Global Influenza Vaccine Sales by Application

6 United States
   6.1 United States Influenza Vaccine Breakdown Data by Company
   6.2 United States Influenza Vaccine Breakdown Data by Type
   6.3 United States Influenza Vaccine Breakdown Data by Application

7 European Union
   7.1 European Union Influenza Vaccine Breakdown Data by Company
   7.2 European Union Influenza Vaccine Breakdown Data by Type
   7.3 European Union Influenza Vaccine Breakdown Data by Application

8 China
   8.1 China Influenza Vaccine Breakdown Data by Company
   8.2 China Influenza Vaccine Breakdown Data by Type
   8.3 China Influenza Vaccine Breakdown Data by Application

9 Rest of World
    9.1 Rest of World Influenza Vaccine Breakdown Data by Company
    9.2 Rest of World Influenza Vaccine Breakdown Data by Type
    9.3 Rest of World Influenza Vaccine Breakdown Data by Application
    9.4 Rest of World Influenza Vaccine Breakdown Data by Countries
        9.4.1 Rest of World Influenza Vaccine Sales by Countries
        9.4.2 Rest of World Influenza Vaccine Revenue by Countries
        9.4.3 Japan
        9.4.4 Korea
        9.4.5 India
        9.4.6 Southeast Asia

10 Company Profiles
    10.1 AstraZeneca
        10.1.1 AstraZeneca Company Details
        10.1.2 Company Description and Business Overview
        10.1.3 Sales, Revenue and Market Share of Influenza Vaccine
        10.1.4 Influenza Vaccine Product Introduction
        10.1.5 AstraZeneca Recent Development
    10.2 CSL
        10.2.1 CSL Company Details
        10.2.2 Company Description and Business Overview
        10.2.3 Sales, Revenue and Market Share of Influenza Vaccine
        10.2.4 Influenza Vaccine Product Introduction
        10.2.5 CSL Recent Development
    10.3 GlaxoSmithKline
        10.3.1 GlaxoSmithKline Company Details
        10.3.2 Company Description and Business Overview
        10.3.3 Sales, Revenue and Market Share of Influenza Vaccine
        10.3.4 Influenza Vaccine Product Introduction
        10.3.5 GlaxoSmithKline Recent Development
    10.4 Sanofi
        10.4.1 Sanofi Company Details
        10.4.2 Company Description and Business Overview
        10.4.3 Sales, Revenue and Market Share of Influenza Vaccine
        10.4.4 Influenza Vaccine Product Introduction
        10.4.5 Sanofi Recent Development
    10.5 Altimmune
        10.5.1 Altimmune Company Details
        10.5.2 Company Description and Business Overview
        10.5.3 Sales, Revenue and Market Share of Influenza Vaccine
        10.5.4 Influenza Vaccine Product Introduction
        10.5.5 Altimmune Recent Development
    10.6 BionVax
        10.6.1 BionVax Company Details
        10.6.2 Company Description and Business Overview
        10.6.3 Sales, Revenue and Market Share of Influenza Vaccine
        10.6.4 Influenza Vaccine Product Introduction
        10.6.5 BionVax Recent Development
    10.7 FluGen
        10.7.1 FluGen Company Details
        10.7.2 Company Description and Business Overview
        10.7.3 Sales, Revenue and Market Share of Influenza Vaccine
        10.7.4 Influenza Vaccine Product Introduction
        10.7.5 FluGen Recent Development
    10.8 Folia Biotech
        10.8.1 Folia Biotech Company Details
        10.8.2 Company Description and Business Overview
        10.8.3 Sales, Revenue and Market Share of Influenza Vaccine
        10.8.4 Influenza Vaccine Product Introduction
        10.8.5 Folia Biotech Recent Development
    10.9 Genentech
        10.9.1 Genentech Company Details
        10.9.2 Company Description and Business Overview
        10.9.3 Sales, Revenue and Market Share of Influenza Vaccine
        10.9.4 Influenza Vaccine Product Introduction
        10.9.5 Genentech Recent Development
    10.10 Green Cross
        10.10.1 Green Cross Company Details
        10.10.2 Company Description and Business Overview
        10.10.3 Sales, Revenue and Market Share of Influenza Vaccine
        10.10.4 Influenza Vaccine Product Introduction
        10.10.5 Green Cross Recent Development
    10.11 Medicago
    10.12 Moderna Therapeutics
    10.13 Novavax
    10.14 Shijiazhuang Yiling Pharmaceutical
    10.15 SK Chemicals
    10.16 UNM Pharma
    10.17 Vaccitec

11 Value Chain and Sales Channels Analysis
    11.1 Value Chain Analysis
    11.2 Sales Channels Analysis
        11.2.1 Influenza Vaccine Sales Channels
        11.2.2 Influenza Vaccine Distributors
    11.3 Influenza Vaccine Customers

12 Market Forecast
    12.1 Global Influenza Vaccine Sales and Revenue Forecast 2019-2025
    12.2 Global Influenza Vaccine Sales Forecast by Type
    12.3 Global Influenza Vaccine Sales Forecast by Application
    12.4 Influenza Vaccine Forecast by Regions
        12.4.1 Global Influenza Vaccine Sales Forecast by Regions 2019-2025
        12.4.2 Global Influenza Vaccine Revenue Forecast by Regions 2019-2025
    12.5 United States Market Forecast
    12.6 European Union Market Forecast
    12.7 China Market Forecast
    12.8 Rest of World
        12.8.1 Japan
        12.8.2 Korea
        12.8.3 India

13 Research Findings and Conclusion

14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
            14.1.1.1 Research Programs/Design
            14.1.1.2 Market Size Estimation
            14.1.1.3 Market Breakdown and Data Triangulation
        14.1.2 Data Source
            14.1.2.1 Secondary Sources
            14.1.2.2 Primary Sources
    14.2 Author Details
    14.3 Disclaimer
List of Tables and Figures

    Figure Influenza Vaccine Product Picture
    Table Influenza Vaccine Key Market Segments
    Table Major Manufacturers Influenza Vaccine Covered in This Report
    Table Global Influenza Vaccine Market Size Growth Rate by Type 2019-2025 (K Units) & (Million US$)
    Figure Global Influenza Vaccine Sales Market Shar by Type 2014-2025
    Figure Fluzone/Vaxigrip Figures
    Table Major Manufacturers of Fluzone/Vaxigrip
    Figure FluMist Figures
    Table Major Manufacturers of FluMist
    Figure Fluarix and Flulaval Figures
    Table Major Manufacturers of Fluarix and Flulaval
    Figure Anflu Figures
    Table Major Manufacturers of Anflu
    Figure Fluvax/Afluria Figures
    Table Major Manufacturers of Fluvax/Afluria
    Figure Flucelvax and Fluvirin Figures
    Table Major Manufacturers of Flucelvax and Fluvirin
    Table Global Influenza Vaccine Market Share by Application 2019-2025 (K Units)
    Figure Adults Use Case
    Figure Pediatrics Use Case
    Figure Senior Citizens Use Case
    Figure Influenza Vaccine Report Years Considered
    Figure Global Influenza Vaccine Market Size 2014-2025 (Million US$)
    Figure Global Influenza Vaccine Sales 2014-2019 (K Units)
    Table Global Influenza Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
    Table Global Influenza Vaccine Sales by Regions 2014-2019 (K Units)
    Table Global Influenza Vaccine Sales Market Share by Regions 2014-2019
    Figure Global Influenza Vaccine Sales Market Share by Regions 2014-2019
    Figure Global Influenza Vaccine Sales Market Share by Regions in 2019
    Table Global Influenza Vaccine Revenue by Regions 2014-2019 (Million US$)
    Table Global Influenza Vaccine Revenue Market Share by Regions 2014-2019
    Figure Global Influenza Vaccine Revenue Market Share by Regions 2014-2019
    Figure Global Influenza Vaccine Revenue Market Share by Regions in 2019
    Table Market Top Trends
    Table Global Influenza Vaccine Sales by Manufacturers (2014-2019) (K Units)
    Table Global Influenza Vaccine Sales Share by Manufacturers (2014-2019)
    Figure Global Influenza Vaccine Sales Share by Manufacturers in 2019
    Table Influenza Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
    Table Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
    Figure Influenza Vaccine Value Share by Manufacturers in 2019
    Table Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Influenza Vaccine Price (2014-2019) (USD/Unit)
    Table Key Manufacturers Influenza Vaccine Plants/Factories Distribution
    Table Key Manufacturers Influenza Vaccine Area Served
    Table Date of Key Manufacturers Enter into Influenza Vaccine Market
    Table Key Manufacturers Influenza Vaccine Product Type
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Fluzone/Vaxigrip Sales and Revenue (2014-2019) (K Units) & (Million US$)
    Table Global FluMist Sales and Revenue (2014-2019) (K Units) & (Million US$)
    Table Global Fluarix and Flulaval Sales and Revenue (2014-2019) (K Units) & (Million US$)
    Table Global Anflu Sales and Revenue (2014-2019) (K Units) & (Million US$)
    Table Global Fluvax/Afluria Sales and Revenue (2014-2019) (K Units) & (Million US$)
    Table Global Flucelvax and Fluvirin Sales and Revenue (2014-2019) (K Units) & (Million US$)
    Table Global Influenza Vaccine Sales by Type (2014-2019) (K Units)
    Table Global Influenza Vaccine Sales Share by Type (2014-2019)
    Figure Global Influenza Vaccine Sales Market Share by Type (2014-2019)
    Figure Global Influenza Vaccine Sales Market Share by Type in 2018
    Table Global Influenza Vaccine Revenue by Type (2014-2019) (Million US$)
    Table Global Influenza Vaccine Revenue Share by Type (2014-2019)
    Figure Global Influenza Vaccine Revenue Market Share by Type (2014-2019)
    Figure Global Influenza Vaccine Revenue Market Share by Type in 2018
    Table Influenza Vaccine Price by Type 2014-2019 (USD/Unit)
    Table Global Influenza Vaccine Sales by Application (2014-2019) (K Units)
    Table Global Influenza Vaccine Sales Share by Application (2014-2019)
    Figure Global Sales Influenza Vaccine Market Share by Application (2014-2019)
    Figure Global Sales Influenza Vaccine Market Share by Application (2014-2019)
    Figure United States Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
    Figure United States Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table United States Influenza Vaccine Sales by Company (2014-2019) (K Units)
    Table United States Influenza Vaccine Sales Market Share by Company (2014-2019)
    Figure United States Influenza Vaccine Sales Market Share by Company in 2019
    Table United States Influenza Vaccine Sales by Type (2014-2019) (K Units)
    Table United States Influenza Vaccine Sales Market Share by Type (2014-2019)
    Figure United States Influenza Vaccine Market Share by Type in 2019
    Table United States Influenza Vaccine Sales by Application (2014-2019) (K Units)
    Table United States Influenza Vaccine Sales Market Share by Application (2014-2019)
    Figure United States Influenza Vaccine Market Share by Application in 2019
    Figure European Union Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
    Figure European Union Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table European Union Influenza Vaccine Sales by Company (2014-2019) (K Units)
    Table European Union Influenza Vaccine Sales Market Share by Company (2014-2019)
    Figure European Union Influenza Vaccine Sales Market Share by Company in 2019
    Table European Union Influenza Vaccine Sales by Type (2014-2019) (K Units)
    Table European Union Influenza Vaccine Sales Market Share by Type (2014-2019)
    Figure 2018 European Union Influenza Vaccine Market Share by Type
    Table European Union Influenza Vaccine Sales by Application (2014-2019) (K Units)
    Table European Union Influenza Vaccine Sales Market Share by Application (2014-2019)
    Figure 2018 European Union Influenza Vaccine Market Share by Application
    Figure China Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
    Figure China Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table China Influenza Vaccine Sales by Company (2014-2019) (K Units)
    Table China Influenza Vaccine Sales Market Share by Company (2014-2019)
    Figure China Influenza Vaccine Sales Market Share by Company in 2019
    Table China Influenza Vaccine Sales by Type (2014-2019) (K Units)
    Table China Influenza Vaccine Sales Market Share by Type (2014-2019)
    Figure China Influenza Vaccine Market Share by Type in 2019
    Table China Influenza Vaccine Sales by Application (2014-2019) (K Units)
    Table China Influenza Vaccine Sales Market Share by Application (2014-2019)
    Figure China Influenza Vaccine Market Share by Application in 2019
    Figure Rest of World Influenza Vaccine Sales Growth Rate 2014-2019 (K Units)
    Figure Rest of World Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
    Table Rest of World Influenza Vaccine Sales by Company (2014-2019) (K Units)
    Table Rest of World Influenza Vaccine Sales Market Share by Company (2014-2019)
    Figure Rest of World Influenza Vaccine Sales Market Share by Company in 2019
    Table Rest of World Influenza Vaccine Sales by Type (2014-2019) (K Units)
    Table Rest of World Influenza Vaccine Sales Market Share by Type (2014-2019)
    Figure Rest of World Influenza Vaccine Market Share by Type in 2019
    Table Rest of World Influenza Vaccine Sales by Application (2014-2019) (K Units)
    Table Rest of World Influenza Vaccine Sales Market Share by Application (2014-2019)
    Figure Rest of World Influenza Vaccine Market Share by Application in 2019
    Table Rest of World Influenza Vaccine Sales by Countries (2014-2019) (K Units)
    Table Rest of World Influenza Vaccine Sales Market Share by Countries (2014-2019)
    Figure Rest of World Influenza Vaccine Sales Market Share by Countries in 2019
    Table Rest of World Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
    Table Rest of World Influenza Vaccine Revenue Market Share by Countries (2014-2019)
    Figure Rest of World Influenza Vaccine Revenue Market Share by Countries in 2019
    Figure Japan Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
    Figure Japan Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units)
    Figure Korea Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
    Figure Korea Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units)
    Figure India Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
    Figure India Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units)
    Figure Southeast Asia Influenza Vaccine Sales Growth Rate (2014-2019) (K Units)
    Figure Southeast Asia Influenza Vaccine Revenue Growth Rate (2014-2019) (K Units)
    Table AstraZeneca Company Details
    Table AstraZeneca Description and Business Overview
    Table AstraZeneca Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table AstraZeneca Influenza Vaccine Sales Growth Rate (2014-2019)
    Table AstraZeneca Influenza Vaccine Sales Market Share in Global Market
    Table AstraZeneca Recent Development
    Table CSL Company Details
    Table CSL Description and Business Overview
    Table CSL Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table CSL Influenza Vaccine Sales Growth Rate (2014-2019)
    Table CSL Influenza Vaccine Sales Market Share in Global Market
    Table CSL Recent Development
    Table GlaxoSmithKline Company Details
    Table GlaxoSmithKline Description and Business Overview
    Table GlaxoSmithKline Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table GlaxoSmithKline Influenza Vaccine Sales Growth Rate (2014-2019)
    Table GlaxoSmithKline Influenza Vaccine Sales Market Share in Global Market
    Table GlaxoSmithKline Recent Development
    Table Sanofi Company Details
    Table Sanofi Description and Business Overview
    Table Sanofi Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Sanofi Influenza Vaccine Sales Growth Rate (2014-2019)
    Table Sanofi Influenza Vaccine Sales Market Share in Global Market
    Table Sanofi Recent Development
    Table Altimmune Company Details
    Table Altimmune Description and Business Overview
    Table Altimmune Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Altimmune Influenza Vaccine Sales Growth Rate (2014-2019)
    Table Altimmune Influenza Vaccine Sales Market Share in Global Market
    Table Altimmune Recent Development
    Table BionVax Company Details
    Table BionVax Description and Business Overview
    Table BionVax Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table BionVax Influenza Vaccine Sales Growth Rate (2014-2019)
    Table BionVax Influenza Vaccine Sales Market Share in Global Market
    Table BionVax Recent Development
    Table FluGen Company Details
    Table FluGen Description and Business Overview
    Table FluGen Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table FluGen Influenza Vaccine Sales Growth Rate (2014-2019)
    Table FluGen Influenza Vaccine Sales Market Share in Global Market
    Table FluGen Recent Development
    Table Folia Biotech Company Details
    Table Folia Biotech Description and Business Overview
    Table Folia Biotech Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Folia Biotech Influenza Vaccine Sales Growth Rate (2014-2019)
    Table Folia Biotech Influenza Vaccine Sales Market Share in Global Market
    Table Folia Biotech Recent Development
    Table Genentech Company Details
    Table Genentech Description and Business Overview
    Table Genentech Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Genentech Influenza Vaccine Sales Growth Rate (2014-2019)
    Table Genentech Influenza Vaccine Sales Market Share in Global Market
    Table Genentech Recent Development
    Table Green Cross Company Details
    Table Green Cross Description and Business Overview
    Table Green Cross Influenza Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2014-2019)
    Table Green Cross Influenza Vaccine Sales Growth Rate (2014-2019)
    Table Green Cross Influenza Vaccine Sales Market Share in Global Market
    Table Green Cross Recent Development
    Table Medicago Company Details
    Table Moderna Therapeutics Company Details
    Table Novavax Company Details
    Table Shijiazhuang Yiling Pharmaceutical Company Details
    Table SK Chemicals Company Details
    Table UNM Pharma Company Details
    Table Vaccitec Company Details
    Figure Influenza Vaccine Value Chain
    Table Influenza Vaccine Distributors List
    Table Influenza Vaccine Customers List
    Table Global Influenza Vaccine Sales Forecast 2019-2025 (K Units) & (Million US$)
    Figure Global Influenza Vaccine Sales Forecast 2019-2025 (K Units)
    Figure Global Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
    Table Global Influenza Vaccine Sales Forecast by Type 2019-2025 (K Units)
    Figure Global Influenza Vaccine Sales Forecast by Type 2019-2025 (K Units)
    Figure Global Influenza Vaccine Sales Market Share Forecast by Type 2019-2025
    Table Global Influenza Vaccine Sales Forecast by Application 2019-2025 (K Units)
    Figure Global Influenza Vaccine Sales Forecast by Application 2019-2025 (K Units)
    Figure Global Influenza Vaccine Sales Market Share Forecast by Application 2019-2025
    Table Global Influenza Vaccine Sales Forecast by Regions 2019-2025 (K Units)
    Figure Global Influenza Vaccine Sales Forecast by Regions 2019-2025 (K Units)
    Figure Global Influenza Vaccine Sales Market Share Forecast by Regions 2019-2025
    Table Global Influenza Vaccine Revenue Forecast by Regions 2019-2025 (K Units)
    Figure Global Influenza Vaccine Revenue Forecast by Regions 2019-2025 (K Units)
    Figure Global Influenza Vaccine Revenue Market Share Forecast by Regions 2019-2025
    Figure United States Influenza Vaccine Sales Forecast 2019-2025 (K Units)
    Figure United States Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
    Figure European Union Influenza Vaccine Sales Forecast 2019-2025 (K Units)
    Figure European Union Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
    Figure China Influenza Vaccine Sales Forecast 2019-2025 (K Units)
    Figure China Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
    Figure Japan Influenza Vaccine Sales Forecast 2019-2025 (K Units)
    Figure Japan Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
    Figure Korea Influenza Vaccine Sales Forecast 2019-2025 (K Units)
    Figure Korea Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
    Figure India Influenza Vaccine Sales Forecast 2019-2025 (K Units)
    Figure India Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
    Figure Southeast Asia Influenza Vaccine Sales Forecast 2019-2025 (K Units)
    Figure Southeast Asia Influenza Vaccine Revenue Forecast 2019-2025 (Million US$)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources